Journal list Promote Sponsor
verified SJR 0,513 · Q3 • database Scopus / SJR & Web of Science indexed
Clinical Lymphoma, Myeloma and Leukemia
United States · Elsevier Inc.
workspace_premium Q3 — Hematology lock Subscription

Clinical Lymphoma, Myeloma and Leukemia

Clinical Lymphoma, Myeloma and Leukemia is a journal indexed in SJR in Hematology and Oncology with an H index of 68. It has a price of 2480 €. It has an SJR impact factor of 0,513 and it has a best quartile of Q3. It has an SJR impact factor of 0,513.

Publisher: Elsevier Inc.
Category: Hematology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,513 Q3
H-index 68
Acceptance rate pie_chart
29% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.480 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,513

H-index

68

Docs (year)

169

Docs 3y

1169

Total refs

6862

Cites 3y

1417

Citable 3y

1144

Cites/Doc 2y

0.95

Ref/Doc

40.6

Immediate OA

2480 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs